Biotech startups that raised Series B in Germany
Updated 16 Nov 2026
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| Computomics | Tübingen | Series B | $7.3M | 2026-08-18 |
| NVision Quantum Technologies | Ulm | Series B | $38.0M | 2026-05-13 |
| Orbem | Munich | Series B | $64.6M | 2026-01-20 |
| Exciva | Heidelberg | Series B | $59.4M | 2026-01-20 |
| Clinomic | Aachen | Series B | $25.3M | 2025-04-08 |
| Qualifyze | Frankfurt | Series B | $54.0M | 2024-09-10 |
| Bind-X | Planegg | Series B | $11.0M | 2023-08-01 |
| Resolve BioSciences | Düsseldorf | Series B | $71.0M | 2022-10-24 |
8 rows of the CSV in 5 of its 18 columns.
- The 35 biotech startups in Germany whose last round is Series B have raised $617.8M in total.
- 5 of them closed their most recent round in the last 12 months, $219.4M combined.
- The largest of those rounds is Orbem's $64.6M Series B, dated January 2026.
- The most recent is Computomics' $7.3M Series B on 18 August 2026.
- HTGF (High-Tech Gruenderfonds) is an investor in 13 of them, more than any other fund.
- Health care is the most common other sector, with 22 companies (63%).
- 3% were founded in 2020 or later; the median founding year is 2012.
- The most common team size is 11 to 50 employees (40% of companies with a recorded size).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
11 of 35| Company | What they do | Sector | City | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| Computomics | Computomics applies artificial intelligence to genomics data to advance agricultural solutions. | Artificial intelligence | Tübingen | Series B | $7.3M | 2026-08-18 | $10.0M | HTGF (High-Tech Gruenderfonds), VentureOut, European Innovation Council +2 | 11 to 50 | 2012 |
| NVision Quantum Technologies | NVision Quantum Technologies develops quantum-based imaging technology that enhances standard MRI systems. | Biotech | Ulm | Series B | $38.0M | 2026-05-13 | $155.2M | Entrée Capital, European Commission, Playground Global +2 | 101 to 250 | 2015 |
| Orbem | Orbem provides AI-powered imaging and analytics for non-invasive biological insights. | Artificial intelligence | Munich | Series B | $64.6M | 2026-01-20 | $106.5M | European Innovation Council, Possible Ventures, 83North +1 | 101 to 250 | 2019 |
| Exciva | Exciva develops clinical-stage biopharmaceutical therapies for neuropsychiatric symptoms of dementia. | Biotech | Heidelberg | Series B | $59.4M | 2026-01-20 | $69.8M | Andera Partners, LBBW VC, Cure8 Ventures | 1 to 10 | 2015 |
| Clinomic | Clinomic is a medical AI company focused on critical care. | Artificial intelligence | Aachen | Series B | $25.3M | 2025-04-08 | $54.6M | German Federal Ministry of Research, Technology and Space | 51 to 100 | 2019 |
| Qualifyze | Qualifyze provides global quality audit and site risk management solutions for life sciences companies. | Biotech | Frankfurt | Series B | $54.0M | 2024-09-10 | Insight Partners, APX, HV Capital +2 | 101 to 250 | 2019 | |
| Resolve BioSciences | Resolve BioSciences conducts biotechnology research in molecular cartography. | Biotech | Düsseldorf | Series B | $71.0M | 2022-10-24 | $95.0M | HTGF (High-Tech Gruenderfonds), EDBI, NRW.BANK +2 | 51 to 100 | 2020 |
| Cardior Pharmaceuticals | Cardior Pharmaceuticals develops medicines and therapies to treat and prevent heart disease. | Biotech | Hanover | Series B | $75.3M | 2021-08-25 | HTGF (High-Tech Gruenderfonds), EQT Life Sciences, Bristol-Myers Squibb +2 | 11 to 50 | 2016 | |
| Topas Therapeutics | Topas Therapeutics is a biotechnology company developing products for major unmet medical needs. | Biotech | Hamburg | Series B | $21.4M | 2021-07-29 | Boehringer Ingelheim Venture Fund, BioMedPartners, Vesalius Biocapital Partners +1 | 51 to 100 | 2006 | |
| Hemovent | Hemovent is an emerging medical device company developing new technology. | Biotech | Aachen | Series B | $5.2M | 2019-02-14 | $13.5M | KfW, NRW.BANK, TechVision Fund +2 | 1 to 10 | 2013 |
| Subitec | Subitec produces microalgae biomass substances for the cosmetics and food additives industries. | Biotech | Stuttgart | Series B | $5.5M | 2012-07-16 | HTGF (High-Tech Gruenderfonds), KfW, eCAPITAL ENTREPRENEURIAL PARTNERS +1 | 11 to 50 | 2000 |
Table 1. Biotech startups that raised Series B in Germany: the 11 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 35.
Largest rounds
Last 12 months| # | Company | What they do | Sector | City | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Orbem | Orbem provides AI-powered imaging and analytics for non-invasive biological insights. | Artificial intelligence | Munich | Series B | $64.6M | 2026-01-20 | $106.5M | European Innovation Council, Possible Ventures, 83North +1 | 101 to 250 | 2019 |
| 2 | Exciva | Exciva develops clinical-stage biopharmaceutical therapies for neuropsychiatric symptoms of dementia. | Biotech | Heidelberg | Series B | $59.4M | 2026-01-20 | $69.8M | Andera Partners, LBBW VC, Cure8 Ventures | 1 to 10 | 2015 |
| 3 | NVision Quantum Technologies | NVision Quantum Technologies develops quantum-based imaging technology that enhances standard MRI systems. | Biotech | Ulm | Series B | $38.0M | 2026-05-13 | $155.2M | Entrée Capital, European Commission, Playground Global +2 | 101 to 250 | 2015 |
| 4 | Computomics | Computomics applies artificial intelligence to genomics data to advance agricultural solutions. | Artificial intelligence | Tübingen | Series B | $7.3M | 2026-08-18 | $10.0M | HTGF (High-Tech Gruenderfonds), VentureOut, European Innovation Council +2 | 11 to 50 | 2012 |
Table 2. Biotech startups that raised Series B in Germany: the 4 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | HTGF (High-Tech Gruenderfonds) | Venture capital firm | Bonn, Germany | 13 | 37% | 1 | Computomics |
| 2 | NRW.BANK | Government investment office | Düsseldorf, Germany | 4 | 11% | ||
| 3 | German Federal Ministry of Research, Technology and Space | Government investment office | Bonn, Germany | 3 | 9% | 1 | NVision Quantum Technologies |
| 4 | Andera Partners | Private equity firm | Paris, France | 3 | 9% | 1 | Exciva |
| 5 | KfW | Government investment office | Frankfurt, Germany | 3 | 9% | ||
| 6 | European Innovation Council | Startup accelerator | Brussels, Belgium | 2 | 6% | 2 | Computomics, Orbem |
| 7 | BASF Venture Capital | Corporate venture arm | Ludwigshafen, Germany | 2 | 6% | 1 | Computomics |
| 8 | Boehringer Ingelheim Venture Fund | Corporate venture arm | Ingelheim Am Rhein, Germany | 2 | 6% | ||
| 9 | EQT Life Sciences | Private equity firm | Amsterdam, The Netherlands | 2 | 6% | ||
| 10 | MIG Capital | Venture capital firm | Munich, Germany | 2 | 6% | ||
| 11 | Bayern Kapital | Venture capital firm | Landshut, Germany | 2 | 6% | ||
| 12 | eCAPITAL ENTREPRENEURIAL PARTNERS | Venture capital firm | Münster, Germany | 2 | 6% | ||
| 13 | Forbion Capital Partners | Private equity firm | Naarden, The Netherlands | 2 | 6% | ||
| 14 | Zukunftsfonds Heilbronn | Venture capital firm | Heilbronn, Germany | 2 | 6% | ||
| 15 | MBG Baden Wuerttemberg | Venture capital firm | Stuttgart, Germany | 1 | 3% | 1 | Computomics |
Table 3. Biotech startups that raised Series B in Germany: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
| Sectors | Companies | Share | Total raised |
|---|---|---|---|
| Health care | 22 | 63% | $501.3M |
| Software | 5 | 14% | $171.2M |
| Artificial intelligence | 3 | 9% | $171.2M |
| Hardware | 1 | 3% | $106.5M |
Table 4. Biotech startups that raised Series B in Germany by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
| Funding stage | Companies | Share | Median last round |
|---|---|---|---|
| Series B | 35 | 100% | $15.3M |
Table 5. Biotech startups that raised Series B in Germany by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Cities
| Cities | Companies | Share |
|---|---|---|
| Munich | 5 | 14% |
| Heidelberg | 2 | 6% |
| Aachen | 2 | 6% |
| Martinsried | 2 | 6% |
| Berlin | 2 | 6% |
| Bielefeld | 2 | 6% |
| Tübingen | 1 | 3% |
| Ulm | 1 | 3% |
| Frankfurt | 1 | 3% |
| Planegg | 1 | 3% |
| Düsseldorf | 1 | 3% |
| Duisburg | 1 | 3% |
Table 6. Biotech startups that raised Series B in Germany by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| August 2026 | 1 | 20% | $7.3M |
| June 2026 | 1 | 20% | $50.0M |
| May 2026 | 1 | 20% | $38.0M |
| January 2026 | 2 | 40% | $124.1M |
Table 7. Biotech startups that raised Series B in Germany: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 5 | 14% | $219.4M |
| 2025 | 1 | 3% | $25.3M |
| 2024 | 1 | 3% | $54.0M |
| 2023 | 1 | 3% | $11.0M |
| 2022 | 3 | 9% | $86.3M |
| 2021 | 6 | 17% | $285.7M |
Table 8. Biotech startups that raised Series B in Germany by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2020 to 2022 | 1 | 3% |
| 2015 to 2019 | 12 | 34% |
| 2010 to 2014 | 9 | 26% |
| Before 2010 | 13 | 37% |
Table 9. Biotech startups that raised Series B in Germany by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 1 to 10 | 7 | 20% |
| 11 to 50 | 14 | 40% |
| 51 to 100 | 8 | 23% |
| 101 to 250 | 5 | 14% |
| 10,001 or more | 1 | 3% |
Table 10. Biotech startups that raised Series B in Germany by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when Biotech is one of its sectors and its most recent funding round is Series B and its headquarters is in Germany. On 16 November 2026 that is 35 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 11 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 35 rows: 6 have no round amount, 0 no city and 15 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many biotech startups in Germany whose last round is Series B are on the list?
- 35, in the file dated 16 November 2026. 5 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 35 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.